Results 211 to 220 of about 30,028 (235)

Treatment of children with heterozygous familial hypercholesterolemia

International Journal of Cardiology, 2020
Željko, Reiner, Amirhossein, Sahebkar
openaire   +2 more sources

Heterozygous familial hypercholesterolemia

Atherosclerosis, 1979
C. Gagné, S. Moorjani, D. Brun, M. Toussaint, P.-J. Lupien   +4 more
openaire   +1 more source

[Colestipol in the treatment of heterozygous familial hypercholesterolemia].

Casopis lekaru ceskych, 1992
In the specialized clinic for disorders of the lipid metabolism 27 patients, 8 men and 19 women, heterozygotes with familial hypercholesterolaemia were treated for 8 weeks with Colestid (colestipol bags a 5 g, Upjohn, Belgium). The administered dose was 15 g colestipol per day. After colestipol treatment the authors recorded a statistically significant
R, Ceska, J, Sobra, H, Toschnerová, J, Traurig   +3 more
openaire   +1 more source

Health Disparities in Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia

The Journal of Pediatrics
To examine the association of social determinants of health and age at heterozygous familial hypercholesterolemia (HeFH) diagnosis and treatment.We performed a retrospective, single-center study of children with HeFH. Multivariable linear regression models were used to examine the association between Child Opportunity Index (COI) and age at HeFH ...
Rachel J. Shustak, Abigail Perlstein, Amanda S. Artis, Alexis Z. Tomlinson, Vicky Tam, Giordana Martino, Julie A. Brothers   +6 more
openaire   +2 more sources

Refractory Hypercholesterolemia in Heterozygous Familial Hypercholesterolemia Treated with Evinacumab

Journal of Clinical Lipidology, 2023
Tiffany Haynes, Laura Grace Kukuc, Robert Fishberg   +2 more
openaire   +1 more source

Skin manifestations in familial heterozygous hypercholesterolemia:

2009
Familial hypercholesterolemia, a form of primary hyperlipoproteinemia, is an autosomal dominant disorder characterized by an increase in serum LDL cholesterol concentrations. Multiple types of xanthomas occur, such as tendinous, tuberous, subperiosteal, and xanthelasma.
Pietroleonardo, Lucia, Ruzicka, Thomas
openaire   +1 more source

iPhone apps for heterozygous familial hypercholesterolemia

Journal of Clinical Lipidology, 2013
Ian G, Thomas, Kristian J, Kiraly, Gregory S, Thomas   +2 more
openaire   +2 more sources

Portacaval shunt for familial heterozygous hypercholesterolemia.

Surgery, gynecology & obstetrics, 1981
Two patients with heterozygous familial type 2 hypercholesterolemia are reported upon following treatment with end-to-side portacaval shunting. In both, the portacaval shunt decreased the cholesterol level by about 40 per cent. No adverse effects of the operation could be seen in either patient at 30 months, and no return of cardiovascular disease is ...
openaire   +1 more source

Heterozygous familial hypercholesterolemia in the clinical management

Atherosclerosis, 2023
N.T. Kim, M.N. Nguyen, D.L. Do, T.T. Le, H.A. Le, T.H. Truong   +5 more
openaire   +1 more source

In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial.

Nature Medicine
Ping Wan, Siyuan Tang, Dongni Lin, Yuming Lu, Mei Long, Ling Xiao, Yanhong Jiang, Jiaoyang Liao, Xiaoying Ma, Ying Liu, Wensu Yu, Michael Ott, Zi Jun Wang, Yuxuan Wu, Taihua Yang, Q. Xia   +15 more
semanticscholar   +1 more source